JZB-27

N/A

Report date: 2022/01/05 15:52:45

Base Information

Drug NameJZB-27
Drug Alias Name聚乙二醇化重组人粒细胞集落刺激因子JZB-27
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Jingze Biotechnology Co LtdHunan Jingfeng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jingze Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A